A Phase I Study of the Combination of Azacitidine, Cyclophosphamide, Vincristine, and Rituximab in Relapsed and Refractory Lymphoma

被引：2
|
作者：
Moss, Jessica J. [1 ]
Howard, Dianna [1 ]
Van Meter, Emily [1 ]
Hayslip, John [1 ]
机构：
[1] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
10.1182/blood.V118.21.1624.1624
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [41] Phase I study of duvelisib in Japanese patients with relapsed or refractory lymphoma
    Izutsu, Koji
    Kato, Koji
    Kiyoi, Hitoshi
    Yamamoto, Go
    Shimada, Kazuyuki
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (04) : 504 - 509
  • [42] Phase I study of duvelisib in Japanese patients with relapsed or refractory lymphoma
    Koji Izutsu
    Koji Kato
    Hitoshi Kiyoi
    Go Yamamoto
    Kazuyuki Shimada
    Koichi Akashi
    International Journal of Hematology, 2020, 112 : 504 - 509
  • [43] Lenalidomide and Rituximab Are a Promising Combination in Vitro, in Vivo Preclinically and in a Phase I/II Clinical Trial in Relapsed/Refractory Mantle Cell Lymphoma
    Wang, Michael
    Zhang, Liang
    Fayad, Luis
    Hagemeister, Fredrick
    Neelapu, Sattva
    Samaniego, Felipe
    Pro, Barbara
    Younes, Anas
    Miller, Scott
    Knight, Robert D.
    Zeldis, Jerome B.
    Yi, Qing
    Romaguera, Jorge
    BLOOD, 2008, 112 (11) : 1051 - 1051
  • [44] Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma
    Arcaini, L
    Orlandi, E
    Scotti, M
    Brusamolino, E
    Passamonti, F
    Burcheri, S
    Colombo, N
    Vanelli, L
    Sbalzarini, G
    Lazzarino, M
    CLINICAL LYMPHOMA, 2004, 4 (04): : 250 - 252
  • [45] A Phase II Study of Temsirolimus (CCI-779) in Combination with Rituximab in Patients with Relapsed or Refractory Mantle Cell Lymphoma.
    Ansell, Stephen M.
    Tang, Hui
    Kurtin, Paul
    Koenig, Patricia
    Inwards, David J.
    Shah, Keith
    Witzig, Thomas E.
    BLOOD, 2009, 114 (22) : 664 - 665
  • [46] A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia
    Kadia, Tapan M.
    Yang, Hui
    Ferrajoli, Alessandra
    Maddipotti, Sirisha
    Schroeder, Claudia
    Madden, Timothy L.
    Holleran, Julianne L.
    Egorin, Merrill J.
    Ravandi, Farhad
    Thomas, Deborah A.
    Newsome, Willie
    Sanchez-Gonzalez, Blanca
    Zwiebel, James A.
    Espinoza-Delgado, Igor
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 72 - 82
  • [47] A phase I study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
    Cash, Thomas
    Jonus, Hunter C.
    Tsvetkova, Maya
    Beumer, Jan Hendrik
    Lee, Jasmine Y.
    Henry, Curtis
    Aguilera, Dolly
    Harvey, R. Donald
    Goldsmith, Kelly C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Phase II: Combination of cladribine, cyclophosphamide, mitoxantrone, rituximab (R-CCM) in patients with relapsed and refractory follicular and mantle cell lymphoma, results of a prospective study at Kitasato University
    Suzuki, Y.
    Danbara, M.
    Hayama, M.
    Togano, T.
    Ohsaka, M.
    Miyazaki, K.
    Horie, R.
    Higashihara, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] A phase I study of clofarabine in combination with cyclophosphamide and etoposide: A new regimen in pediatric patients with refractory or relapsed acute leukemia
    Hijiya, N.
    Franklin, J.
    Rytting, M.
    Cooper, T.
    Chu, R.
    Barry, E.
    McCarthy, C.
    Abichandani, R.
    Carroll, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia
    Murthy, Guru Subramanian Guru
    Saliba, Antoine N.
    Szabo, Aniko
    Harrington, Alexandra
    Abedin, Sameem
    Carlson, Karen
    Michaelis, Laura
    Runaas, Lyndsey
    Baim, Arielle
    Hinman, Alex
    Maldonado-Schmidt, Sonia
    Venkatachalam, Annapoorna
    Flatten, Karen S.
    Peterson, Kevin L.
    Schneider, Paula A.
    Litzow, Mark
    Kaufmann, Scott H.
    Atallah, Ehab
    HAEMATOLOGICA, 2024, 109 (09) : 2864 - 2872
12345